Search results for "Breast cancer cells"

showing 10 items of 38 documents

Cross-talk between fibroblast and breast cancer cells: a proteomic study

2003

Proteomicfibroblastbreast cancer cells
researchProduct

A contribution to breast cancer cell proteomics: detection of new sequences

2002

Ductal infiltrating carcinoma (DIC) of the breast is the most common and potentially aggressive form of cancer. Knowledge of proteomic profiles, attained both in vivo and in vitro, is fundamental to acquire as much information as possible on the proteins expressed in these pathologic conditions. We used the breast cancer cell line 8701-BC, established from a primary DIC, with the aim of contributing to the databases on mammary cancer cells, which in turn will be very useful for the identification of differentially expressed proteins in normal and neoplastic cells. Within an analysis window comprising about 1750 discernible spots, we have at present catalogued 84 protein spots. The proteins …

ProteomicsDatabases FactualMolecular Sequence DataBreast NeoplasmsComputational biologyBiologyProteomicsBioinformaticsBiochemistryImmune systemBreast cancerBreast cancerIn vivoSequence Analysis ProteinmedicineTumor Cells CulturedHumansElectrophoresis Gel Two-DimensionalSettore BIO/06 - Anatomia Comparata E CitologiaMolecular BiologyCarcinoma Ductal BreastCancermedicine.diseaseIn vitroNeoplasm ProteinsCancer cellFemaleBreast cancer cells
researchProduct

Effect of collagen substrates on proteomic modulation of breast cancer cells

2004

We have previously described the occurrence, in breast and colon cancer extra-cellular matrix, of an oncofoetal form of collagen, OF/LB, able to induce an increase in cell proliferation and motility in the breast cancer cell line 8701-BC. It also caused an increased amount of type V collagen which appears to exert an anti-proliferative effect on the same cells. The aim of the present study was to investigate, at the proteomic level, the effect of OF/LB and type V collagens used as substrates for neoplastic cell growth. Due to the complexity of a whole proteomic profile, a subset of significant protein classes was used to assess variations in protein expression levels. For this study we adop…

ProteomicsGene isoformmedicine.medical_specialtyHot TemperatureProteomeMotilityBreast NeoplasmsBiologyMatrix (biology)ProteomicsBiochemistryproteomic breast cancer cells collagenBreast cancerSettore BIO/13 - Biologia ApplicataCell Line TumorInternal medicineHeat shock protein[SDV.BBM] Life Sciences [q-bio]/Biochemistry Molecular BiologyImage Processing Computer-AssistedmedicineHumansElectrophoresis Gel Two-DimensionalMolecular BiologyHeat-Shock ProteinsProteomic ProfileProteinsmedicine.diseaseCell biologyEndocrinologySpectrometry Mass Matrix-Assisted Laser Desorption-IonizationMultivariate AnalysisNeoplastic cellCollagenCell DivisionPROTEOMICS
researchProduct

Breast cancer cells exhibit selective modulation induced by different collagen substrates.

2008

During the invasive phase of malignant tumors, neoplastic cells break into the basal lamina and enter in contact with the underlying connective tissue, which concurrently undergoes extensive modifications. The aim of our present minireview is to focus the changes in the collagenous matrix occurring during breast cancer progression and to explore the possible effects of different collagen substrates on breast cancer cell behavior and proteomic modulation.

ProteomicsPathologymedicine.medical_specialtyConnective tissueBreast NeoplasmsMatrix (biology)ProteomicsBiochemistryBreast cancerRheumatologymedicineAnimalsHumansOrthopedics and Sports MedicineNeoplasm InvasivenessNeoplasm MetastasisSettore BIO/06 - Anatomia Comparata E Citologiaskin and connective tissue diseasesCollagen substrateMolecular BiologyCollagen Substrate Breast Cancer ProteomicsChemistryCell Biologymedicine.diseaseExtracellular MatrixSelective modulationSettore BIO/18 - Geneticamedicine.anatomical_structureCancer researchBasal laminaBreast cancer cellsCollagenStromal Cells
researchProduct

Multiple changes induced by fibroblasts on breast cancer cells.

2010

It is now widely recognised that the cross-talk between cancer and stromal cells may play a crucial role in cancer progression. However little is known about the complex underlying molecular mechanisms that occur within the tumor microenvironment. Fibroblasts are the major stromal cells with multiple roles, especially towards both the extracellular matrix and the neighbouring cell population, including neoplastic cells. Consequently, proteomic analyses would provide a wider resource for a better understanding of the potential modulating effects exerted by fibroblasts on cancer cells. In this report we describe the effects of fibroblast stimulation on the breast cancer cell line (8701-BC) pr…

ProteomicsStromal cellProteomeCellGenes mycBreast NeoplasmsCell CommunicationBiologyBiochemistryProto-Oncogene Proteins c-mycRheumatologyCell MovementCell Line TumormedicineHumansOrthopedics and Sports MedicineNeoplasm InvasivenessSettore BIO/06 - Anatomia Comparata E CitologiaFibroblastMolecular BiologyCell ProliferationTumor microenvironmentOncogeneCancerCell BiologyFibroblastsmedicine.diseaseCoculture TechniquesCell biologyUp-RegulationGene Expression Regulation NeoplasticCytoskeletal Proteinsmedicine.anatomical_structureCulture Media ConditionedSpectrometry Mass Matrix-Assisted Laser Desorption-IonizationCancer cellNeoplastic cellproteomics breast cancer cells fibroblasts invasion assay cell proliferation.FemaleStromal CellsConnective tissue research
researchProduct

Gene and protein signatures associated to treatment of MDA-MB231 breast cancer cells with JAHA, a novel histone deacetylase inhibitor

2014

Settore BIO/06 - Anatomia Comparata E Citologiabreast cancer cells histone deacetylase inhibitor
researchProduct

The effect of the HDACi JAHA on DNA methylation of breast cancer cells by down-regulating DNMT1 through ERK signaling

2014

Settore BIO/06 - Anatomia Comparata E Citologiahistone deacetylase inhibitor breast cancer cells DNMT1 ERK
researchProduct

Evaluation of the in vitro and in vivo antineoplastic effects of Parthenolide on MDA-MB231 breast cancer cells

2012

Triple-negative breast cancer refers to an aggressive subtype of breast cancer in which the tumor cells lack receptors for estrogen, progesterone and the HER2 protein on their surfaces. This type of breast cancer does not respond to treatments such as hormone therapy, like tamoxifen and aromatase inhibitors, or drugs that target HER2, like Herceptin. It is important, therefore, the identification of new selective drugs for the treatment of these tumors. Parthenolide (PN), a sesquiterpene lactone extracted from the medical plant Tanacetum parthenium, exerts anticancer activity on several tumor cell lines in culture, acting through diverse molecular mechanisms. Our previous studies have shown…

Settore BIO/10 - BiochimicaBreast cancer cells sesquiterpene lactones parthenolide DMAPT
researchProduct

Potential miRNAs involved in molecular pathways mediating the anticancer effects of short term starvation in breast cancer cells treated with doxorub…

2017

Background: In recent years, increasing evidences showed that several types of dietary approaches restricting food intake, including Short Term Starvation (STS), may exert a protective role against aging and other age-related pathologies as well as cancer. Interestingly, the dietary restriction showed significant anticancer effects able to prevent cancer onset, slow its progression and improve therapy response. Since recent studies showed that miRNAs may modulate sensibility/resistance to antiblastic therapy, the aim of our study was to investigate the STS-induced molecular changes in breast cancer cells treated with doxorubicin, focusing our attention on miRNA expression profile. Materials…

StarvationOncologymedicine.medical_specialtyChemotherapybusiness.industrymedicine.medical_treatmentHematologymedicine.diseaseBreast cancerOncologyInternal medicinemicroRNAMiRNAs Breast cancer Starvation ChemotherapymedicineDoxorubicinBreast cancer cellsmedicine.symptombusinessmedicine.drugAnnals of Oncology
researchProduct

Cytotoxic bufadienolides from the leaves of a medicinal plant Melianthus comosus collected in South Africa.

2020

Abstract From the leaves of South African medicinal plant Melianthus comosus, four previously undescribed bufadienolides, 16β-formyloxymelianthugenin (1), 2β-acetoxymelianthusigenin (2), 2β-hydroxy-3β,5β-di-O-acetylhellebrigenin (3), and 2β-acetoxy-5β-O-acetylhellebrigenin (4) were isolated together with two known bufadienolides. The structural elucidation of the compounds was based on 1D and 2D NMR spectroscopy, high-resolution mass spectrometry, and other spectroscopic methods. The relative configurations were determined by single-crystal X-ray crystallography analysis and NOESY correlations. The isolated compounds displayed strong cytotoxicity against MCF-7 breast cancer cells, sensitive…

StereochemistryMolecular ConformationMass spectrometry01 natural sciencesBiochemistrySouth AfricaStructure-Activity RelationshipCell Line TumorDrug DiscoveryIc50 valuesCytotoxic T cellHumansCytotoxicityMolecular BiologyCell ProliferationPlants MedicinalbiologyDose-Response Relationship Drug010405 organic chemistryChemistryOrganic ChemistryStereoisomerismMelianthus comosusbiology.organism_classificationAntineoplastic Agents Phytogenic0104 chemical sciencesBufanolidesPlant Leaves010404 medicinal & biomolecular chemistryBreast cancer cellsDrug Screening Assays AntitumorTwo-dimensional nuclear magnetic resonance spectroscopyBioorganic chemistry
researchProduct